Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Diagnostic Clinique/diagnostic, Betacoronavirus/effets des médicaments et des substances chimiques, Infections à coronavirus/diagnostic, Pneumopathie virale/diagnostic, Hypoxie/diagnostic, Acuité des besoins du patient, Infections à coronavirus/traitement médicamenteux, Pneumopathie virale/traitement médicamenteux, Dexaméthasone/usage thérapeutique, Allaitement naturel, Antiviraux/usage thérapeutique, Hydroxychloroquine/usage thérapeutique, Colchicine/usage thérapeutique, Plasma sanguin/immunologie, Darunavir/usage thérapeutique, Interférons/usage thérapeutique, Pratique factuelle/méthodes